U.K. Bioindustry Plots Its Post-Brexit Course
Improving Manufacturing of Advanced Therapies Is One of Several Initiatives Being Put in Place
GEN Roundup: Kinase Assays from Preliminary Screens to “Smart” Deployment
GEN Interviewed Six Experts to Explore Kinase Assays
When the Pressure Is High the Dementia Is Low
Sounds of Science Podcast
Tuning Up or Taming Immune Responses
New Immunotherapeutic Strategies Include Bispecific Antibodies, Engineered Adenoviruses, and Specifically Formulated Vaccines against Cancer
Reprints And Permissions
Genetic Engineering & Biotechnology News (GEN) is pleased to announce our partnership with Copyright Clearance Center to meet your licensing needs.
With Copyright Clearance Center's Rightslink® service it's faster and easier than ever before to secure permission from GEN to reuse our content in a book, journal/magazine, newsletter/newspaper, CD-ROM/DVD, brochure/pamphlet, photocopy, coursepack, email, slide kit/presentation or order reprints.
Simply locate your desired content on http://www.genengnews.com/, click the Reprints link in the Keywords and Tools section to open Rightslink.
- Select the way you would like to reuse the content
- Create an account if you haven't already
- Accept the terms and conditions and you're done
For questions about using the Rightslink service, please contact Customer Support via phone 877/622-5543 (toll free) or 978/777-9929, or email [email protected]
If you prefer, please contact us directly:
Reprints & Permissions
Mary Ann Liebert, Inc., publishers
(914) 740-2100 or (800) M-LIEBERT